Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Transcera Inc
Profile last edited on: 3/11/2024      CAGE: 8HNJ5      UEI: PG4ZWW1DSX69

Business Identifier: Unlocking the Potential of Biologic Medicine
Year Founded
2020
First Award
2023
Latest Award
2023
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

700 Main Street
Cambridge, MA 02139
   (978) 592-2906
   info@transcera.com
   www.transcera.com
Location: Single
Congr. District: 07
County: Middlesex

Public Profile

Currently there is no description available for this company.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$324,905
Phase II Dollars
$0
Total Awarded
$324,905

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
0 1 NIH $324,905
Project Title: Oral Delivery of Therapeutic Peptides for Type II Diabetes and Obesity by Harnessing Endogenous Sphingolipid Trafficking

Key People / Management

  William H Goble -- Co-Founder & CEO

  Jiaqian Li -- Scientist

  Christina Mcguire -- Principal Scientist

  Deepa Patil -- Scientist II

  Joanna Podkalicka -- Senior Scientist

  Justin Mahoney Wolfe -- Co-Founder & CSO

Company News

There are no news available.